Table 1 Baseline demographic, clinical, laboratory and medication-related characteristics of children on ART at Debre-Markos Referral Hospital, Northwest Ethiopia from March 2005 to April 2017 (n = 352)
From: Incidence of tuberculosis in children on antiretroviral therapy: a retrospective cohort study
Characteristics | Categories | Frequency | Percent (%) |
|---|---|---|---|
Age | 0–5 year | 140 | 39.8 |
5–10 year | 154 | 43.7 | |
10–15 year | 58 | 16.5 | |
Sex | Male | 179 | 50.9 |
Female | 173 | 49.1 | |
Residence | Urban | 313 | 88.9 |
Rural | 39 | 11.1 | |
Parent status | Both parents alive | 248 | 70.5 |
Paternal and maternal orphan | 80 | 22.7 | |
Double orphan | 24 | 6.8 | |
WHO clinical stage | Stage 1 and 2 | 275 | 78.1 |
Stage 3 and 4 | 77 | 21.9 | |
CD4 count | Below threshold | 69 | 19.6 |
Above threshold | 283 | 80.4 | |
Hemoglobin level | < 10 mg/dl | 50 | 14.2 |
≥ 10 mg/dl | 302 | 85.8 | |
Nutritional status | Underweight | 82 | 22.3 |
Normal | 270 | 76.7 | |
Ever taking cotrimoxazole preventive therapy | Yes | 331 | 94.0 |
No | 21 | 6.0 | |
Ever taking isoniazid prophylaxis therapy | Yes | 110 | 31.2 |
No | 242 | 68.8 | |
Months on care before ART | ≤ 3 month | 290 | 82.4 |
> 3 months | 62 | 17.6 | |
ART adherence | Good | 301 | 85.5 |
Ever had fair and poor | 51 | 14.5 | |
Months on care after ART | ≤ 6 month | 56 | 15.9 |
> 6 month | 296 | 84.1 |